Multimedia content is supported by an unrestricted educational grant from:

Scientific Agenda

History of EGFR targeted therapies in NSCLC
Kaoru Kubota, MD

Contemporary strategies for targeting EGFR in NSCLC
Karen Kelly, MD

The emerging role of EGFR inhibitory antibodies in combination with radiation
Walter J. Curran, Jr, MD